To determine whether CagA-mediated enhancement of colitis involves the signaling pathway that activates NF-κB, we compared the levels of IκBα, a major isoform of the NF-κB inhibitor IκB, in cagA-Tg mice and control mice. Here, NFKB1 is linked to colitis.